Американское общество гирудотерапии

Peripheral Artery Disease (Claudication, Investigational)

Highly investigational adjunct for intermittent claudication; ABI must be assessed first; critical limb ischemia is an absolute contraindication.

Tier C — InvestigationalИсследовательское применениеLast updated: 2026-05-26 · Reviewed by ASH Editorial Board

Краткая информация для пациента

Есть ли FDA-допуск для этого показания?
Not FDA-cleared for peripheral artery disease. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use for PAD is highly investigational.
Какие доказательства существуют?
Tier C (highly investigational). A handful of small uncontrolled case reports describe walking-distance improvement; there are no randomized controlled trials and no data on amputation, MI, or stroke prevention. Evidence-based PAD care per AHA/ACC 2016 guidelines includes smoking cessation, statin therapy, antiplatelet medication (aspirin or clopidogrel), structured supervised exercise (the strongest evidence for claudication), and revascularization (angioplasty / bypass) for lifestyle-limiting disease or critical limb ischemia. Leech therapy on a leg with poor arterial flow can cause tissue breakdown.
Основные риски
  • Tissue breakdown, non-healing wound, or gangrene if applied to a limb with low ABI (under 0.6) — this is the dominant risk
  • Bleeding from bite sites for 6 to 24 hours after detachment
  • Local skin infection or, rarely, Aeromonas infection
  • Worsening anemia from cumulative blood loss
  • Allergic reaction to leech saliva (uncommon)
  • Bleeding interaction with antiplatelet medications (aspirin, clopidogrel) — usually required for PAD
  • Delay or replacement of evidence-based therapy with risk of amputation, MI, or stroke
Кому не следует это рассматривать
  • Patients with ABI under 0.6 (critical limb ischemia)
  • Patients on antiplatelet therapy (aspirin, clopidogrel) — required for most PAD patients
  • Patients with a diabetic foot ulcer or active gangrene
  • Patients within 6 weeks of vascular intervention (angioplasty, stenting, bypass)
  • Patients with rest pain or non-healing wounds (urgent vascular surgery indication)
  • Patients with active infection, hemophilia, or severe anemia
О чём спросить врача
  • What is my ankle-brachial index (ABI) and toe-brachial index, and what is my Rutherford / Fontaine class?
  • Am I on a statin and appropriate antiplatelet therapy?
  • Have I tried supervised exercise therapy — the highest-evidence intervention for claudication?
  • Am I a candidate for revascularization (angioplasty, stent, bypass)?
  • What is my vascular surgery team's opinion on adjunctive complementary therapy?
  • If antiplatelet must continue, is leech therapy compatible at all?
  • What is the practitioner's experience and Aeromonas-prevention plan?
Когда срочно обратиться за медицинской помощью
  • Sudden severe leg pain, coldness, pallor, or pulselessness (acute limb ischemia — call 911)
  • Rest pain that interferes with sleep, or a non-healing leg or foot wound
  • New gangrene, blackening, or ulceration
  • Chest pain, pressure, or shortness of breath
  • Sudden weakness, slurred speech, facial droop, or vision loss
  • Bleeding from a bite site lasting more than 24 to 48 hours, fever, spreading redness, or pus
  • Hives, throat tightness, or breathing difficulty

Что это НЕ означает

  • This is not FDA-cleared for peripheral artery disease.
  • Small uncontrolled reports do NOT establish efficacy on walking distance vs. supervised exercise or on cardiovascular outcomes.
  • Mechanism rationale (microvascular flow) does NOT fix proximal arterial stenosis.
  • Leech therapy is NEVER a substitute for supervised exercise, statin / antiplatelet therapy, or revascularization when indicated.
  • Critical limb ischemia requires urgent vascular surgical evaluation, NOT complementary therapy.

Clinical Profile

Category
cardiovascular
ICD-10
I70.211, I70.212, I70.213, I73.9
Safety tier
high

Evidence Summary

Peripheral artery disease management follows AHA/ACC guidelines: smoking cessation, statin and antiplatelet therapy, supervised exercise, and revascularization for lifestyle-limiting claudication or critical limb ischemia. No controlled trial or case series of hirudotherapy for PAD or claudication has been published; use for this indication is investigational and mechanistic only. Critical safety: leech application to a limb with an ankle-brachial index <0.6 risks tissue breakdown and gangrene, and most PAD patients require antiplatelet therapy, which is an exclusion for leech application.

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)

Key Trials

  1. Andereya S et al. (2008), n=18

Contraindications

  • Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
  • Hemophilia or other bleeding disorder
  • Severe anemia (Hb <10 g/dL)
  • Active bacteremia or sepsis
  • Known hypersensitivity to leech salivary proteins
  • Pregnancy (relative — first/third trimester)
  • Immunocompromised state with severe neutropenia
  • Active deep vein thrombosis (acute phase <2 weeks)
  • Critical limb ischemia (ABI <0.4)
  • ABI <0.6 (critical limb ischemia)
  • Antiplatelet therapy (aspirin, clopidogrel) — absolute exclusion
  • Diabetic foot ulcer or active gangrene
  • Recent vascular intervention (<6 weeks)
  • Concurrent statin-related rhabdomyolysis

Related Conditions

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.

Peripheral Artery Disease (Claudication, Investigational) — Hirudotherapy Evidence | ASH